01 1AX Pharmaceutical Corp
01 1Clascoterone
01 1Canada
NDC Package Code : 73377-304
Start Marketing Date : 2024-12-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
20
PharmaCompass offers a list of Clascoterone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clascoterone manufacturer or Clascoterone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clascoterone manufacturer or Clascoterone supplier.
PharmaCompass also assists you with knowing the Clascoterone API Price utilized in the formulation of products. Clascoterone API Price is not always fixed or binding as the Clascoterone Price is obtained through a variety of data sources. The Clascoterone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A breezula manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of breezula, including repackagers and relabelers. The FDA regulates breezula manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. breezula API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of breezula manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A breezula supplier is an individual or a company that provides breezula active pharmaceutical ingredient (API) or breezula finished formulations upon request. The breezula suppliers may include breezula API manufacturers, exporters, distributors and traders.
click here to find a list of breezula suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing breezula as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for breezula API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture breezula as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain breezula and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a breezula NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of breezula suppliers with NDC on PharmaCompass.
We have 1 companies offering breezula
Get in contact with the supplier of your choice:
